Wikipedia -WSS

Wikipedia

author：explore 2025-09-30 17:45:12 - browse：177

Treeline Northwest — AP Photo/Ted S. Warren

Josh Bilenker’s last company, Loxo Oncology, was purchased by Eli Lilly for $8 billion. No surprise, then, that his next effort has already raised at least $473 million in funding from private investors even before telling the public what, exactly, it is working on.

Treeline Biosciences, the new venture by Bilenker and Jeffrey Engelman, formerly Novartis’s top cancer researcher, has hired more than 130 people across three research sites in little more than a year, according to a company blog post, regulatory filings, and STAT reporting.

Treeline’s website doesn’t mention a single drug target or disease. In a paper published last year in Nature Cancer, Engelman and several colleagues reviewed the history of a class of cancer drugs called PI3 kinase inhibitors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Coercive sterilizations revealed by STAT prompt outrage

WSS

5 takeaways from STAT's examination of Zynex Medical

Digital health: a case of mistaken identity

Medical device trials still don't enroll enough women, study finds

New report analyzes digital physical therapy solutions' effectiveness

ASCO eve: Let’s set the table for this year's meeting

Citing H5N1 threat, CDC urges peak flu monitoring this summer

focus

Wikipedia

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

As a primary care physician, here's how I hope to partner with AI

Apple is now the first public company to be valued at $3 trillion

Reports of telehealth's death have been greatly exaggerated

Continuity nursing helped my family in our darkest PICU moments

Moderna says combo Covid

Sports medicine is finally prioritizing gender equality

Making the case for fair compensation in clinical trials

In Memoriam: Notable people who died in 2023

Curing rare childhood diseases will falter unless Congress steps up

leisure time

Questions and answers about ramping up H5N1 bird flu vaccine

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Statins may not be needed by millions of people, study suggests

Stephen Quake on the Chan Zuckerberg quest to conquer disease

New report analyzes digital physical therapy solutions' effectiveness

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

focus

explore

Wikipedia

focus